Post-approval studies (Phase 4)Study completedNCT00687076
What this trial is testing
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Who this might be right for
Peripheral Arterial Disease
Baylor College of Medicine 102